Exhibit 1091

Cochrane's Editor in Chief responds to BMJ EBM article criticizing HPV review

Exhibit 1091 · Institutional statement

Cochrane's Editor in Chief responds to BMJ EBM article criticizing HPV review

The BMJ Evidence-Based Medicine article substantially overstated its criticisms.

Responds to the 27 July 2018 BMJ Evidence-Based Medicine article by Gøtzsche and Jefferson on Cochrane's HPV vaccine review. Says an investigation with review authors, editors and independent researchers found the review did not miss 'nearly half of the eligible trials' and that the article 'substantially overstated its criticisms.'

Source: Cochrane (Editor in Chief David Tovey)
Date: 29 August 2018
Quoted from: Key findings, last bullet
Grade: Primary record
Document: https://www.cochrane.org/about-us/news/cochranes-editor-chief-responds-bmj-ebm-article-criticizing-hpv-review
Accessed: 2026-11-10
Cited by: Findings citing this exhibit
Note: Cochrane's Board gave other grounds for the 25 September 2018 expulsion (exhibit 944). Research-side counterstatements are in the Gøtzsche library entry (response items 3-12).

Cited by

Finding INF-5.14: Primary record Cochrane's Governing Board voted unanimously on 25 September 2018 to end Peter Gøtzsche's membership, his Board seat and his directorship of the Nordic Cochrane Centre, citing a pattern of disruptive behavior, personal views presented as Cochrane's, and breaches of trustee confidentiality. Cochrane's editor in chief had written on 29 August 2018 that the BMJ Evidence-Based Medicine article by Gøtzsche and a coauthor on Cochrane's HPV vaccine review "substantially overstated its criticisms."